Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan;128(1):169-182.
doi: 10.1111/bcpt.13481. Epub 2020 Sep 7.

Bromodomain 4 is a potent prognostic marker associated with immune cell infiltration in breast cancer

Limei Zhong  1 , Zhiyong Yang  1 , Da Lei  1 , Lijuan Li  1 , Shaohua Song  1 , Donglin Cao  1 , Yufeng Liu  2   3
Affiliations
Free article

Bromodomain 4 is a potent prognostic marker associated with immune cell infiltration in breast cancer

Limei Zhong et al. Basic Clin Pharmacol Toxicol. 2021 Jan.
Free article

Abstract

Bromodomain 4 (BRD4), a member of the bromodomain and extra-terminal domain protein family, has become a promising epigenetic target in cancer and inflammatory diseases; however, the detailed biological role of BRD4 in breast cancer (BRCA) remains undetermined. We analysed the BRD4 expression levels using the Oncomine and TIMER databases and evaluated the clinical impact of BRD4 on BRCA prognosis using Kaplan-Meier plot and PrognoScan. The correlation between BRD4 and tumour-infiltrating immune cells was investigated using TIMER. Furthermore, the correlation between BRD4 expression levels was also analysed using TIMER in addition to the GEPIA database for immune cell gene markers. BRD4 expression was significantly higher in BRCA tissues than in normal tissues, which was significantly correlated with poor overall survival (OS). Specifically, high BRD4 expression was correlated with worse OS and progression-free survival in patients with BRCA. In addition, BRD4 expression was correlated with levels of infiltrating monocytes (CSF1R, cor = 0.204, P = 9.19e-12), tumour-associated macrophages (CD68, cor = 0.129, P = 1.81e-05), M1/M2 macrophages and different effector T cells (including Th1/Th2/Treg) in BRCA. These findings suggest that BRD4 could be used as a prognostic biomarker for determining prognosis and immune cell infiltration levels in BRCA.

Keywords: BRD4; breast cancer; immune infiltration; prognostic marker; prognostic value.

PubMed Disclaimer

References

REFERENCES

    1. Bertos NR, Park M. Breast cancer-one term, many entities? J Clin Invest. 2011;121(10):3789-3796.
    1. Polyak K, Shipitsin M, Campbell-Marrotta L, et al. Breast tumor heterogeneity: causes and consequences. Breast Cancer Res. 2009;23(11):S18.
    1. Sui Y, Ju C, Shao B. A lymph node metastasis-related protein-coding genes combining with long noncoding RNA signature for breast cancer survival prediction. J Cell Physiol. 2019;234(11):20036-20045.
    1. Chen B, Tang H, Chen X, et al. Transcriptomic analyses identify key differentially expressed genes and clinical outcomes between triple-negative and non-triple-negative breast cancer. Cancer Manag Res. 2018;11:179-190.
    1. Tang H, Huang X, Wang J, et al. circKIF4A acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancer. Mol Cancer 2019;02(11):18.

MeSH terms

LinkOut - more resources